Mark R Hurtt

Title: Mark R Hurtt: Innovator in Central Nervous System Research

Introduction

Mark R Hurtt is a notable inventor based in Wallingford, CT (US). He has made significant contributions to the field of neuroscience, particularly in the area of central nervous system (CNS) research. With a total of 2 patents, his work focuses on innovative methods for treating and assessing conditions affecting the CNS.

Latest Patents

Mark R Hurtt's latest patents include groundbreaking methods for modulating axonal outgrowth of central nervous system neurons. One patent details systemic purine administration techniques that stimulate axonal outgrowth following injuries such as stroke, traumatic brain injury, and spinal cord injury. Another patent presents a method for imaging dopamine transporter levels in the CNS using SPECT imaging, which involves administering a labeled dopamine transporter ligand and assessing its binding through a specific imaging protocol.

Career Highlights

Mark R Hurtt is currently associated with Alseres Pharmaceuticals, Inc., where he continues to advance his research in CNS therapies. His innovative approaches have the potential to significantly impact the treatment of neurological conditions.

Collaborations

Throughout his career, Mark has collaborated with esteemed colleagues, including Noel James Cusack and Richard M Thorn. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic methods.

Conclusion

Mark R Hurtt is a distinguished inventor whose work in central nervous system research is paving the way for new treatment methodologies. His contributions are vital to advancing our understanding and treatment of neurological injuries and disorders.